薪資待遇:
50萬 + 績效獎金,期權(quán)。匯報對象VP或者CEO
具體薪資待遇看個人經(jīng)驗背景等
崗位介紹:
1.根據(jù)公司所從事的雙特異抗體, 多特異抗體等PD-1后時代First-in-Class (FIC) 抗腫瘤藥物研發(fā)之方向,開展商務(wù)工作,包括C輪融資,在研項目中、美授權(quán)轉(zhuǎn)讓等工作。
應(yīng)聘要求:
1. 具有腫瘤免疫領(lǐng)域大分子新藥研發(fā)經(jīng)驗3年以上且從事領(lǐng)域相關(guān)商務(wù)工作3年以上,有過項目轉(zhuǎn)讓或者融資成功案例。
2. 生物學(xué)相關(guān)碩士、博士或者MBA具有生物醫(yī)藥領(lǐng)域項目轉(zhuǎn)讓,創(chuàng)業(yè)公司早期階段融資工作經(jīng)驗3年以上。
3. 具有非常強的溝通、交流、處事能力
4. 具有良好團隊合作意識、敬業(yè)以及創(chuàng)新創(chuàng)業(yè)精神
職能類別:醫(yī)藥領(lǐng)域商務(wù)
關(guān)鍵字:新藥研發(fā)商務(wù)
BD Manager or Director or VP,
L&L Biopharma Co., LTD., Shanghai, China (www.lnlbio.com) is a clinical-stage biotech focused on the development of novel therapies for the treatment of cancers. The company focuses on exploring the first in class (FIC) bispecific/trispecific antibody products targeting post PD-1 market. Two products Bis5 and Bis2 are currently on the phase I study. We are looking for BD talents in different level including manager, director or VP to join in our team.
Job responsibilities:
ü Identifies and develops business opportunities, including fund raising and product out-licensing
ü Builds partnerships for the phase I and II studies of Bis2 and/or Bis5 in China and US
ü Maintain and strengthens relationships with existing partnerships and investors
ü Based in Shanghai and/or New Jersey or other states in US
Qualifications and skills:
ü Strategic planning skills and knowledge of bi/tri-specific antibody for the treatment of cancers
ü Excellent presentation and communication skills
ü Ability to communicate accessibly and concisely about products to prospective partners and investors
ü Bachelor’s degree in business administration, marketing, economy or related field. MBA with experience in biologics biotech is highly preferred
ü 2+ years related experience is great